Corey Strickland

VP, Molecular Technology at Proteovant Therapeutics

Corey has 25+ years in building structural biology drug discovery platforms across multiple disease areas. Previously Senior Principal Scientist at Merck.

Links

Previous companies

Org chart

View in org chart

Manager

Drew Fromkin

CEO

Peers

Zhihua Sui

Chief Scientific Officer

Helai Mohammad

VP, Biology

Scott Priestley

VP, Discovery Chemistry

View in org chart

Timeline

VP, Molecular Technology
Current role

A panel showing how The Org can help with contacting the right person.